Cargando…

Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients

Circulating tumor DNA (ctDNA) has been utilized to monitor the clinical course of patients of non-small-cell lung cancer (NSCLC) who receive therapies targeting druggable mutations. However, despite providing valuable information on how NSCLC would naturally progress, the clinical utility of ctDNA f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Woo Kyung, Oh, Sekyung, Lim, Jun Hyeok, Lee, Seung Jae, Shin, Hyun-Tae, Ryu, Jeong-Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455735/
https://www.ncbi.nlm.nih.gov/pubmed/36076922
http://dx.doi.org/10.3390/ijms23179527

Ejemplares similares